肾细胞癌肾切除术中下腔静脉血栓的保守治疗。

Victor Gaillard , Thibault Tricard , Pietro Addeo , Lucie Aussenac-Belle , Baptiste Poussot , Véronique Lindner , Hervé Lang
{"title":"肾细胞癌肾切除术中下腔静脉血栓的保守治疗。","authors":"Victor Gaillard ,&nbsp;Thibault Tricard ,&nbsp;Pietro Addeo ,&nbsp;Lucie Aussenac-Belle ,&nbsp;Baptiste Poussot ,&nbsp;Véronique Lindner ,&nbsp;Hervé Lang","doi":"10.1016/j.urolonc.2024.08.018","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To assess the impact on survival outcomes of positive vascular margins (PVM) after nephrectomy, open thrombectomy and renal vein ostium resection without inferior vena cava (IVC) segmental resection for nonmetastatic clear cell renal cell carcinoma (ccRCC).</div></div><div><h3>Materials and methods</h3><div>Medical records of patients undergoing nephrectomy and open thrombectomy for ccRCC in 1 center were retrospectively reviewed. Baseline characteristics, pathological features and surgery parameters were collected. A Cox uni- and multivariate regression model was used to evaluate the association between common prognosis factors including PVM and survival outcomes.</div></div><div><h3>Results</h3><div>Thirty-nine patients were included. Median age was 65 (55–74) years, mean tumor size was 101±35.7mm, 35/39 (89%) had an infra-diaphragmatic IVC thrombus, and on pathological examination 19 (49%) and 17 (44%) patients had a Fuhrman/ISUP grade 3 and grade 4 ccRCC, respectively, and 23 (59%) had PVM. The median overall survival (OS), cancer specific survival (CSS) and disease-free survival (DFS) were 66, 116 and 28 months, respectively. In the univariate analysis, OS was significantly shorter in case of PVM (HR 4.21, <em>P</em> = 0.01), but there was no significative impact on CSS, local recurrence and DFS. In the multivariate analysis, PVM had no impact on OSS, CSS, local recurrence and DFS, but metastatic lymph nodes were associated with a higher risk of death (HR 4.37, <em>P</em> = 0.015), local recurrence (HR 9.98, <em>P</em> = 0.004) and disease progression (HR 6.09, <em>P</em> = 0.002) and a supra-diaphragmatic thrombus was associated with a higher risk of local recurrence (HR 13.83, <em>P</em> = 0.007) and disease progression (HR 7.77, <em>P</em> = 0.003).</div></div><div><h3>Conclusion</h3><div>In a population with a high rate of positive vascular margins, inferior vena cava wall invasion had a minimal impact on survival outcomes. This must be considered regarding the invasiveness of the surgery used for these patients.</div></div>","PeriodicalId":23408,"journal":{"name":"Urologic Oncology-seminars and Original Investigations","volume":"42 12","pages":"Pages 452.e21-452.e28"},"PeriodicalIF":2.4000,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Conservative management of inferior vena cava thrombus during nephrectomy for renal cell carcinoma\",\"authors\":\"Victor Gaillard ,&nbsp;Thibault Tricard ,&nbsp;Pietro Addeo ,&nbsp;Lucie Aussenac-Belle ,&nbsp;Baptiste Poussot ,&nbsp;Véronique Lindner ,&nbsp;Hervé Lang\",\"doi\":\"10.1016/j.urolonc.2024.08.018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To assess the impact on survival outcomes of positive vascular margins (PVM) after nephrectomy, open thrombectomy and renal vein ostium resection without inferior vena cava (IVC) segmental resection for nonmetastatic clear cell renal cell carcinoma (ccRCC).</div></div><div><h3>Materials and methods</h3><div>Medical records of patients undergoing nephrectomy and open thrombectomy for ccRCC in 1 center were retrospectively reviewed. Baseline characteristics, pathological features and surgery parameters were collected. A Cox uni- and multivariate regression model was used to evaluate the association between common prognosis factors including PVM and survival outcomes.</div></div><div><h3>Results</h3><div>Thirty-nine patients were included. Median age was 65 (55–74) years, mean tumor size was 101±35.7mm, 35/39 (89%) had an infra-diaphragmatic IVC thrombus, and on pathological examination 19 (49%) and 17 (44%) patients had a Fuhrman/ISUP grade 3 and grade 4 ccRCC, respectively, and 23 (59%) had PVM. The median overall survival (OS), cancer specific survival (CSS) and disease-free survival (DFS) were 66, 116 and 28 months, respectively. In the univariate analysis, OS was significantly shorter in case of PVM (HR 4.21, <em>P</em> = 0.01), but there was no significative impact on CSS, local recurrence and DFS. In the multivariate analysis, PVM had no impact on OSS, CSS, local recurrence and DFS, but metastatic lymph nodes were associated with a higher risk of death (HR 4.37, <em>P</em> = 0.015), local recurrence (HR 9.98, <em>P</em> = 0.004) and disease progression (HR 6.09, <em>P</em> = 0.002) and a supra-diaphragmatic thrombus was associated with a higher risk of local recurrence (HR 13.83, <em>P</em> = 0.007) and disease progression (HR 7.77, <em>P</em> = 0.003).</div></div><div><h3>Conclusion</h3><div>In a population with a high rate of positive vascular margins, inferior vena cava wall invasion had a minimal impact on survival outcomes. This must be considered regarding the invasiveness of the surgery used for these patients.</div></div>\",\"PeriodicalId\":23408,\"journal\":{\"name\":\"Urologic Oncology-seminars and Original Investigations\",\"volume\":\"42 12\",\"pages\":\"Pages 452.e21-452.e28\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-09-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urologic Oncology-seminars and Original Investigations\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1078143924006355\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology-seminars and Original Investigations","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1078143924006355","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的评估非转移性透明细胞肾细胞癌(ccRCC)肾切除术、开放性血栓切除术和肾静脉骨膜切除术后血管边缘阳性(PVM)对生存结果的影响:回顾性分析1个中心接受肾切除术和开放性血栓切除术治疗ccRCC患者的病历。收集了基线特征、病理特征和手术参数。采用Cox单变量和多变量回归模型评估包括PVM在内的常见预后因素与生存结果之间的关系:结果:共纳入 39 例患者。中位年龄为 65(55-74)岁,平均肿瘤大小为 101±35.7mm,35/39(89%)例患者有膈下 IVC 血栓,病理检查结果分别为 19(49%)例和 17(44%)例患者为 Fuhrman/ISUP 3 级和 4 级 ccRCC,23(59%)例患者有 PVM。总生存期(OS)、特定癌症生存期(CSS)和无病生存期(DFS)的中位数分别为 66 个月、116 个月和 28 个月。在单变量分析中,PVM 患者的 OS 明显较短(HR 4.21,P = 0.01),但对 CSS、局部复发和 DFS 没有明显影响。在多变量分析中,PVM 对 OSS、CSS、局部复发和 DFS 没有影响,但转移性淋巴结与较高的死亡风险(HR 4.37,P = 0.015)、局部复发(HR 9.98,P = 0.004)和疾病进展(HR 6.09,P = 0.002)相关,膈上血栓与较高的局部复发风险(HR 13.83,P = 0.007)和疾病进展风险(HR 7.77,P = 0.003)相关:结论:在血管边缘阳性率较高的人群中,下腔静脉壁侵犯对生存结果的影响很小。结论:在血管边缘阳性率较高的人群中,下腔静脉壁侵犯对生存预后的影响很小,这必须考虑到这些患者所采用手术的侵犯性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Conservative management of inferior vena cava thrombus during nephrectomy for renal cell carcinoma

Objectives

To assess the impact on survival outcomes of positive vascular margins (PVM) after nephrectomy, open thrombectomy and renal vein ostium resection without inferior vena cava (IVC) segmental resection for nonmetastatic clear cell renal cell carcinoma (ccRCC).

Materials and methods

Medical records of patients undergoing nephrectomy and open thrombectomy for ccRCC in 1 center were retrospectively reviewed. Baseline characteristics, pathological features and surgery parameters were collected. A Cox uni- and multivariate regression model was used to evaluate the association between common prognosis factors including PVM and survival outcomes.

Results

Thirty-nine patients were included. Median age was 65 (55–74) years, mean tumor size was 101±35.7mm, 35/39 (89%) had an infra-diaphragmatic IVC thrombus, and on pathological examination 19 (49%) and 17 (44%) patients had a Fuhrman/ISUP grade 3 and grade 4 ccRCC, respectively, and 23 (59%) had PVM. The median overall survival (OS), cancer specific survival (CSS) and disease-free survival (DFS) were 66, 116 and 28 months, respectively. In the univariate analysis, OS was significantly shorter in case of PVM (HR 4.21, P = 0.01), but there was no significative impact on CSS, local recurrence and DFS. In the multivariate analysis, PVM had no impact on OSS, CSS, local recurrence and DFS, but metastatic lymph nodes were associated with a higher risk of death (HR 4.37, P = 0.015), local recurrence (HR 9.98, P = 0.004) and disease progression (HR 6.09, P = 0.002) and a supra-diaphragmatic thrombus was associated with a higher risk of local recurrence (HR 13.83, P = 0.007) and disease progression (HR 7.77, P = 0.003).

Conclusion

In a population with a high rate of positive vascular margins, inferior vena cava wall invasion had a minimal impact on survival outcomes. This must be considered regarding the invasiveness of the surgery used for these patients.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.80
自引率
3.70%
发文量
297
审稿时长
7.6 weeks
期刊介绍: Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.
期刊最新文献
Editorial Board Table of Contents Cover 2 - Masthead 2023 Star Reviewers for Urologic Oncology Cover 3 - Information for Authors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1